HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Unaltered anionic sites of glomerular basement membrane in aminonucleoside nephrosis.

Abstract
Quantitative electron microscopic autoradiography was employed to determine the changes in the binding of 125I-cationic ferritin (CFI, pI approximately 7.2 to 7.4) to the anionic sites of the glomerular basement membrane (GBM) of rats following the induction of nephrosis. Animals were rendered nephrotic by a single intravenous injection of puromycin aminonucleoside (PAN) and sacrificed 0, 7, 14, and 21 days after its administration. CFI (10 mg/mCi/100 g body weight) was given intravenously. The kidneys were subsequently fixed by perfusion and processed for electron microscopic autoradiography. The mean grain densities over the GBMs on 0, 7, 14, and 21 days of PAN nephrosis were 1.50 +/- 0.04, 1.49 +/- 0.05, 1.50 +/- 0.05, and 1.51 +/- 0.04, respectively. These results indicate that there are no significant alterations in the anionic sites rich in heparan sulfate proteoglycan during the entire course of PAN nephrosis.
AuthorsY S Kanwar, M L Jakubowski
JournalKidney international (Kidney Int) Vol. 25 Issue 4 Pg. 613-8 (Apr 1984) ISSN: 0085-2538 [Print] United States
PMID6482165 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Iodine Radioisotopes
  • Puromycin Aminonucleoside
  • Ferritins
Topics
  • Animals
  • Basement Membrane (metabolism)
  • Ferritins
  • Iodine Radioisotopes
  • Kidney Glomerulus (metabolism)
  • Male
  • Nephrosis (chemically induced, metabolism, pathology)
  • Puromycin Aminonucleoside
  • Rats
  • Rats, Inbred Strains

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: